| Product NDC: | 0591-3965 | 
| Proprietary Name: | Progesterone | 
| Non Proprietary Name: | Progesterone | 
| Active Ingredient(s): | 200 mg/1 & nbsp; Progesterone | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0591-3965 | 
| Labeler Name: | Watson Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019781 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20100730 | 
| Package NDC: | 0591-3965-01 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (0591-3965-01) | 
| NDC Code | 0591-3965-01 | 
| Proprietary Name | Progesterone | 
| Package Description | 100 CAPSULE in 1 BOTTLE (0591-3965-01) | 
| Product NDC | 0591-3965 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Progesterone | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 20100730 | 
| Marketing Category Name | NDA | 
| Labeler Name | Watson Pharmaceuticals, Inc. | 
| Substance Name | PROGESTERONE | 
| Strength Number | 200 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Progesterone [Chemical/Ingredient],Progesterone [EPC] |